Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ABL1 Antikörper (AA 830-910)

Der Kaninchen Polyklonal anti-ABL1 Antikörper (ABIN7213898) detektiert spezifisch ABL1 in WB, ELISA, IF und IHC (p). Dieser Antikörper reagiert spezifisch mit Proben aus Human, Maus und Ratte.
Produktnummer ABIN7213898
-15% Promotion 2026
530,08 €
623,62 €
Sparen Sie 93,54 € (-15 %)
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 10 bis 14 Werktagen

Kurzübersicht für ABL1 Antikörper (AA 830-910) (ABIN7213898)

Target

Alle ABL1 Antikörper anzeigen
ABL1 (C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1))

Reaktivität

  • 225
  • 133
  • 96
  • 12
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Maus, Ratte

Wirt

  • 307
  • 5
Kaninchen

Klonalität

  • 306
  • 6
Polyklonal

Konjugat

  • 112
  • 18
  • 17
  • 15
  • 11
  • 11
  • 11
  • 11
  • 11
  • 11
  • 11
  • 11
  • 11
  • 11
  • 11
  • 9
  • 8
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Dieser ABL1 Antikörper ist unkonjugiert

Applikation

  • 213
  • 143
  • 143
  • 121
  • 66
  • 52
  • 36
  • 33
  • 19
  • 18
  • 12
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
  • Bindungsspezifität

    • 40
    • 26
    • 20
    • 16
    • 15
    • 15
    • 15
    • 15
    • 15
    • 15
    • 15
    • 15
    • 12
    • 9
    • 8
    • 7
    • 7
    • 6
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 830-910

    Verwendungszweck

    c-Abl Polyclonal Antibody

    Spezifität

    C-Abl Polyclonal Antibody detects endogenous levels of c-Abl protein.

    Aufreinigung

    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen

    Immunogen

    Synthesized peptide derived from the C-terminal region of human c-Abl at AA range: 830-910

    Isotyp

    IgG
  • Applikationshinweise

    Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), IHC-P (1:100-1:300), IF (1:200-1:1000), ELISA (1:20000). Not yet tested in other applications.

    Kommentare

    Primary Antibody

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
  • Target

    ABL1 (C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1))

    Andere Bezeichnung

    c-Abl

    Hintergrund

    Rabbit Anti-c-Abl Polyclonal Antibody,ABL1, ABL, JTK7, Tyrosine-protein kinase ABL1, Abelson murine leukemia viral oncogene homolog 1, Abelson tyrosine-protein kinase 1, Proto-oncogene c-Abl, p150,ABL1 is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein (ABL proto-oncogene 1, non-receptor tyrosine kinase) is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t (9,22) translocation that results in a fusion with the 5' end of the breakpoint cluster region gene (BCR, MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons.,Tyrosine-protein kinase ABL1

    Molekulargewicht

    observerd band 125(200kd BCR-ABL complex)kDa

    Gen-ID

    25

    UniProt

    P00519

    Pathways

    Apoptose, Regulation of Muscle Cell Differentiation, Platelet-derived growth Factor Receptor Signaling, Lipid Metabolism
Sie sind hier:
Chat with us!